Ratings by Piper Sandler
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 4/15/2024 | Christopher Raymond | Ultragenyx Pharma | RARE | Maintain | Overweight (N/A) |
130.00 (N/A) |
|
Details | |
| 4/15/2024 | Christopher J. Raymond | Biohaven Pharmaceutical Holding | BHVN | Maintain | Overweight (N/A) |
66.00 (N/A) |
|
Details | |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 19,005 more... | |||||||||
